Loading live market data…

Cerevel Therapeutics Holdings, Inc.

NASDAQ:CERE

$44.96 USD

$0.33 (0.74%)

Volume
15.03M
Average Volume
2.11M
Market Capitalization
$8.19B
P/E Ratio
-16.84
Dividend Yield
0.00%
Price Target
$33.50
Year High
$44.99
Year Low
$19.59
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$10.92

CERE Estimated and Actual Revenue by Quarter

CERE Estimated and Actual EPS by Quarter

CERE Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2025-09-30 0 - - - - - -
2025-06-30 0 - - - - - -
2025-03-31 0 - - - - - -
2024-12-31 0 - - - - - -
2024-09-30 0 - - - - - -
2024-06-30 0 - - - - - -
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2025-09-30 0 -138.02M -138.02M -138.02M - - -
2025-06-30 0 -132.58M -132.58M -132.58M - - -
2025-03-31 0 -130.76M -130.76M -130.76M - - -
2024-12-31 0 -154.37M -154.37M -154.37M - - -
2024-09-30 0 -155.41M -90.66M -131.67M - - -
2024-06-30 0 - - - - - -
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2025-09-30 0 - - - 1 -0.76 -0.76 -0.76
2025-06-30 0 - - - 1 -0.73 -0.73 -0.73
2025-03-31 0 - - - 1 -0.72 -0.72 -0.72
2024-12-31 0 - - - 1 -0.85 -0.85 -0.85
2024-09-30 0 - - - 3 -0.85574 -0.49918 -0.725
2024-06-30 0 - - - 1 0 0 0